Mirum Pharmaceuticals, Inc. (MIRM) Q2 2024 Earnings Call Transcript [Seeking Alpha]
Mirum Pharmaceuticals, Inc. - common stock (MIRM)
Last mirum pharmaceuticals, inc. - common stock earnings: 3/12 04:02 pm
Check Earnings Report
Company Research
Source: Seeking Alpha
Follow Q2: 2024-08-07 Earnings Summary Play Call Press Release 10-Q EPS of -$0.52 misses by $0.03 | Revenue of $77.88M (107.68% Y/Y) beats by $2.79M Mirum Pharmaceuticals, Inc. ( NASDAQ: MIRM ) Q2 2024 Results Conference Call August 7, 2024 4:30 PM ET Company Participants Andrew McKibben - Vice President, Investor Relations Chris Peetz - Chief Executive Officer Peter Radovich - President & Chief Operating Officer Joanne Quan - Chief Medical Officer Eric Bjerkholt - Chief Financial Officer Conference Call Participants Jon Wolleben - Citizens JMP Steven Seedhouse - Raymond James David Lebowitz - Citi Mike Ulz - Morgan Stanley Jessica Fye - JPMorgan Gavin Clark-Gartner - Evercore ISI Mani Foroohar - Leerink Partners Dae Gon Ha - Stifel Operator Good afternoon, everyone, and welcome to the Mirum Pharmaceuticals reports Second Quarter 2024 Financial Results and provides Business Update. My name is Carla, and I will be coordinating your call to
Show less
Read more
Impact Snapshot
Event Time:
MIRM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MIRM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MIRM alerts
High impacting Mirum Pharmaceuticals, Inc. - common stock news events
Weekly update
A roundup of the hottest topics
MIRM
News
- Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire
- Mirum Pharmaceuticals to Participate in Upcoming Investor ConferencesBusiness Wire
- Mirum Pharmaceuticals to Announce Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024 [Yahoo! Finance]Yahoo! Finance
- Mirum Pharmaceuticals to Announce Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024Business Wire
- Mirum Pharmaceuticals to Showcase LIVMARLI Data from its ALGS and PFIC Programs at the NASPGHAN Annual MeetingBusiness Wire
MIRM
Earnings
- 8/7/24 - Miss
MIRM
Sec Filings
- 10/22/24 - Form SC
- 10/1/24 - Form 4
- 9/20/24 - Form 4
- MIRM's page on the SEC website